[1] STEPHEN M, MATTHEW J, STEVEN C, et al. Elevated pretreatment serum levels of interferon-inducible protein-10(CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients[J]. Am J Hematol, 2012, 87(9): 865. doi: 10.1002/ajh.23259
[2] WITZIG TE, MAURER MJ, STENSON MJ, et al. Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma[J]. Am J Hematol, 2014, 89(4): 417. doi: 10.1002/ajh.23658
[3] ZENG YJ, LAI W, WU H, et al. Neuroendocrine-like cells -derived CXCL10 and CXCL11 induce the infiltration of tumor-associated macrophage leading to the poor prognosis of colorectal cancer[J]. Oncotarget, 2016, 7(19): 27394. doi: 10.18632/oncotarget.8423
[4] ZHOU H, WU J, WANG T, et al. CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production[J]. Biomed Pharmacother, 2016, 82: 479. doi: 10.1016/j.biopha.2016.04.069
[5] 孙书豪, 巩发海, 彭根远, 等. CXCL10/CXCR3轴对结直肠癌SW480、SW620细胞侵袭及上皮间质化的影响[J]. 宁夏医科大学学报, 2019, 41(6): 541.
[6] LI L, ZHU YH, LI Y, et al. Identification of chemokine CXCL10 in tumor microenvironment by antibody array as a prognostic marker in hepatocellular carcinoma[J]. Neoplasma, 2017, 64(5): 778. doi: 10.4149/neo_2017_517
[7] JAFARZADEH A, FOOLADSERESHT H, NEMATI M, et al. Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism[J]. Cancer Biomark, 2016, 16(4): 545. doi: 10.3233/CBM-160596
[8] BAI M, CHEN X, BA YI. CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage Ⅱ colorectal cancer[J]. Mol Clin Oncol, 2016, 4(1): 23. doi: 10.3892/mco.2015.665
[9] XU M, LI D, YANG C, et al. MicroRNA-34a Inhibition of the TLR signaling pathway via CXCL10 suppresses breast cancer cell invasion and migration[J]. Cell Physiol Biochem, 2018, 46(3): 1286. doi: 10.1159/000489111
[10] MOTEGI T, TOMIYASU H, GOTO-KOSHINO Y, et al. Prognostic value of CD44 variant isoform expression in dogs with multicentric high-grade B-cell lymphoma[J]. Am J Vet Res, 2018, 79(9): 961. doi: 10.2460/ajvr.79.9.961
[11] 韦花媚, 刘坤平, 罗春英, 等. MMP-9及HIF-1α在鼻NK/T细胞淋巴瘤表达中的作用研究[J]. 中国免疫学杂志, 2016, 32(6): 863. doi: 10.3969/j.issn.1000-484X.2016.06.020
[12] 葛建娟, 杨书云, 宋诸臣, 等. 耐药相关基因在复发难治性非霍奇金淋巴瘤中的表达及临床意义[J]. 江苏医药, 2016, 42(15): 1669.
[13] HONG JY, RYU KJ, LEE JY, et al. Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphoma[J]. Hematol Oncol, 2017, 35(4): 480. doi: 10.1002/hon.2374
[14] LIN C, YAN H, YANG J, et al. Combination of DESI2 and IP10 gene therapy significantly improves therapeutic efficacy against murine carcinoma[J]. Oncotarget, 2017, 8(34): 56281. doi: 10.18632/oncotarget.17623